🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07613398
Starting soon Observational

An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function

NCT07613398 · tracked via the Priya Life Science Germany tracker
Sponsor
Matthias Stuber
Phase
Observational
Started
2026-06
Last updated
2026-05-29

Condition(s) studied

Congenital Heart DiseasesCardiac Diseases

Study summary

This project aims to evaluate a new cardiac MRI technique called the Free-Running Framework (FRF), which could simplify and accelerate the process of acquiring cardiac images. The investigators want to verify whether this method can provide functional heart measurements comparable to those obtained with traditional methods. More specifically, the goal of the study is to compare the measurements obtained with FRF to those obtained with standard sequences, to ensure they match and that this new approach can be reliably used in clinical practice. The FRF technique works differently from standard cardiac MRI. In standard exams, patients are asked to hold their breath several times and small electrodes (ECG) are used to monitor the heartbeat during the scan. These steps are needed to get clearer images of the heart as it moves. With FRF, these steps are no longer necessary: the scan is performed while patients' breath normally and without ECG monitoring. In addition, standard MRI takes multiple 2D slices of the heart, one after another. The FRF method instead captures a 3D image of the entire heart in one go, which can improve the consistency of the exam and reduce errors when doctors analyze the images later. This is all possible because the FRF method records data continuously and then organizes the images afterward based on how participants heart and breathing were moving during the exam. This helps the imager to get clear images of the heart, even without breath-holding or ECG monitoring. This project is aimed at individuals with heart disease who require cardiac MRI exams to monitor their health status (age ≥ 18 years) and are able to clearly understand the instructions provided by the research team. The investigators have already conducted small-scale technical and feasibility studies using FRF. These studies have shown that FRF is easy to use, faster than traditional methods, and provides image quality comparable to standard imaging techniques. The investigators now wish to evaluate its use in a clinical setting. More specifically, the investigators need to verify that FRF provides the same essential diagnostic information as standard techniques, so that it can be reliably used in future patient care. A maximum of 300 participants will be included in the investigation of this MRI technique between 2026 and 2031. This is a multi-center study, conducted internationally across 18 centers.

This project is being carried out in compliance with Swiss legislation. The investigators follow all internationally recognized guidelines. The competent ethics committee has reviewed and approved this project.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with cardiac disease of any complexity and scheduled for a clinical cardiac MRI on a clinical 1.5T MRI scanner * Able to understand and provide written informed consent or, for minors, ability to provide assent with written consent from a parent/legal representative, per local law and site policy prior to the study * Ability to undergo MRI without contraindications * Agrees to be informed in the event of incidental findings Exclusion Criteria: * Severe claustrophobia preventing MRI completion * Presence of non-MRI compatible implants (e.g., pacemakers, certain metallic implants) * Contraindications to the intravenous contrast agent * Movement disorders or inability to remain still during the scan

Primary outcome measure(s)

Trial sites (20)

FacilityCityRegionStatus
University of California, Los Angeles Los Angeles California
Emory University Atlanta Georgia
Ann & Robert H Lurie Children's Hospital of Chicago Chicago Illinois
Boston's Children Hospital Boston Massachusetts
Mayo Clinic Rochester Minnesota
Washington University in St. Louis St Louis Missouri
Ohio State University Columbus Ohio
Children's Hospital of Philadelphia Philadelphia Pennsylvania
UT Southwestern Medical Center Dallas Texas
University of Melbourne Melbourne Victoria
Fundacion Cardioinfantil-LaCardio Bogotá Capital District
University of Bonn Bonn North Rhine-Westphalia
Cologne University Medical Center Cologne North Rhine-Westphalia
Charité - Universitätsmedizin Berlin Berlin State of Berlin
Università Cattolica - Fondazione Policlinico Gemelli IRCCS Rome Lazio
Mie University Tsu Mie-ken
Maastricht University Medical Center Maastricht Limburg
National University of Singapore Singapore Singapore
University of Cape Town Cape Town Western Cape
King's College London London London
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07613398 on ClinicalTrials.gov ↗ ← All trials in Germany